These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 19335813

  • 1. Treatment of cutaneous leishmaniasis in travelers 2009.
    Blum JA, Hatz CF.
    J Travel Med; 2009; 16(2):123-31. PubMed ID: 19335813
    [No Abstract] [Full Text] [Related]

  • 2. Back from the Peace Corps--with skin lesions from South America.
    Sorci JJ, Cordova X, Usatine RP.
    J Fam Pract; 2003 Jul; 52(7):531-6. PubMed ID: 12884834
    [No Abstract] [Full Text] [Related]

  • 3. Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.
    Bermúdez H, Rojas E, Garcia L, Desjeux P, Dujardin JC, Boelaert M, Chappuis F.
    Ann Trop Med Parasitol; 2006 Oct; 100(7):591-600. PubMed ID: 16989685
    [Abstract] [Full Text] [Related]

  • 4. South American cutaneous leishmaniasis: report of ten cases in Israeli travelers.
    Zlotogorski A, Gilead L, Jonas F, Horev L, Klaus SN.
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):32-6. PubMed ID: 9731963
    [Abstract] [Full Text] [Related]

  • 5. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
    Krolewiecki AJ, Romero HD, Cajal SP, Abraham D, Mimori T, Matsumoto T, Juarez M, Taranto NJ.
    Am J Trop Med Hyg; 2007 Oct; 77(4):640-6. PubMed ID: 17978064
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Two cases of Old World cutaneous leishmaniasis in Australian travelers visiting Morocco.
    Stewardson AJ, Leder K, Torresi J, Johnson DF.
    J Travel Med; 2010 Oct; 17(4):278-80. PubMed ID: 20636604
    [Abstract] [Full Text] [Related]

  • 9. Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens.
    Oliveira-Neto MP, Schubach A, Mattos M, Gonçalves-Costa SC, Pirmez C.
    Pathol Biol (Paris); 1997 Jun; 45(6):496-9. PubMed ID: 9309267
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate.
    Shamsi Meymandi S, Zandi S, Aghaie H, Heshmatkhah A.
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):587-91. PubMed ID: 20666876
    [Abstract] [Full Text] [Related]

  • 11. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.
    Momeni AZ, Aminjavaheri M.
    Eur J Dermatol; 2003 May; 13(1):40-3. PubMed ID: 12609780
    [Abstract] [Full Text] [Related]

  • 12. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z, Nakhli A, Rassaii S.
    Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Postkala-azar dermal leishmaniasis].
    de Juan Martín F, Justa Roldán ML, Sáez de Adana Pérez E, Navarro Serrano E, Bouthelier Moreno M, Gilaberte Calzada Y, Fortuño Cebamanos B.
    An Esp Pediatr; 1997 Jan; 46(1):63-4. PubMed ID: 9082890
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.
    Salmanpour R, Razmavar MR, Abtahi N.
    Int J Dermatol; 2006 Sep; 45(9):1115-6. PubMed ID: 16961529
    [No Abstract] [Full Text] [Related]

  • 16. [American cutaneous leishmaniasis: special features in diagnosis and therapy].
    Bormann G, William T, Schulz A, Marsch W, Gaber G.
    Dtsch Med Wochenschr; 2003 Oct 02; 128(40):2065-8. PubMed ID: 14523685
    [Abstract] [Full Text] [Related]

  • 17. Antimony in plasma and skin of patients with cutaneous leishmaniasis--relationship with side effects after treatment with meglumine antimoniate.
    Neves DB, Caldas ED, Sampaio RN.
    Trop Med Int Health; 2009 Dec 02; 14(12):1515-22. PubMed ID: 19954451
    [Abstract] [Full Text] [Related]

  • 18. [Glucantime reaction with fatal outcome following treatment of cutaneous leishmaniasis].
    Hajlaoui K, Zeglaoui F, Ezzine N, Kastalli S, Elfekih N, Fazaa B, Loueslati MH, Kamoun MR.
    Ann Dermatol Venereol; 2008 Apr 02; 135(4):317-8. PubMed ID: 18420083
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
    Soto J, Rea J, Balderrama M, Toledo J, Soto P, Valda L, Berman JD.
    Am J Trop Med Hyg; 2008 Feb 02; 78(2):210-1. PubMed ID: 18256415
    [Abstract] [Full Text] [Related]

  • 20. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
    Soto J, Valda-Rodriquez L, Toledo J, Vera-Navarro L, Luz M, Monasterios-Torrico H, Vega J, Berman J.
    Am J Trop Med Hyg; 2004 Nov 02; 71(5):577-81. PubMed ID: 15569787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.